FIXIX
Price
$40.86
Change
-$0.15 (-0.37%)
Updated
Jun 2 closing price
Net Assets
5.61B
PICOX
Price
$46.28
Change
-$0.24 (-0.52%)
Updated
Jun 2 closing price
Net Assets
342.72M
Interact to see
Advertisement

FIXIX vs PICOX

Header iconFIXIX vs PICOX Comparison
Open Charts FIXIX vs PICOXBanner chart's image
FIXIX vs PICOX Comparison Chart in %
View a ticker or compare two or three
VS
FIXIX vs. PICOX commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FIXIX is a Hold and PICOX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FIXIX has more cash in the bank: 5.61B vs. PICOX (343M). PICOX pays higher dividends than FIXIX: PICOX (5.98) vs FIXIX (2.98). FIXIX was incepted earlier than PICOX: FIXIX (23 years) vs PICOX (8 years). PICOX (1.15) is less costly to investors than FIXIX (0.95). PICOX is a more actively managed with annual turnover of: 30.00 vs. FIXIX (24.00). FIXIX (0) and PICOX (0) have matching initial minimum investment requirements. FIXIX annual gain was more profitable for investors over the last year : 18.68 vs. PICOX (4.45). FIXIX return over 5 years is better than : 29.49 vs. PICOX (11.90).
FIXIXPICOXFIXIX / PICOX
Total Expense Ratio0.951.0590%
Annual Report Gross Expense Ratio0.951.1583%
Fund Existence23 years8 years-
Gain YTD10.5993.217329%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets5.61B343M1,636%
Annual Yield % from dividends2.985.9850%
Returns for 1 year18.684.45420%
Returns for 3 years49.9940.32124%
Returns for 5 years29.4911.90248%
Returns for 10 years94.10N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CNM50.481.40
+2.85%
Core & Main
STEL37.370.59
+1.60%
Stellar Bancorp
CRACU10.22N/A
N/A
Crown Reserve Acquisition Corp. I
DWTX1.68-0.02
-1.18%
Dogwood Therapeutics Inc
IPSC2.18-0.18
-7.63%
Century Therapeutics